Apollo Ventures is a venture capital firm in Germany that focuses on assets that treat, prevent, or even reverse age-related diseases such as alzheimer's, heart disease, sarcopenia, frailty, and cancer, with the goal of increasing healthy human lifespan. Founded 2016 in Hamburg, Germany by James Peyer, Nils Regge and Ole Mensching, and this venture capital firm invests in early stage ventures and seed. Its portfolio companies include Aeovian Pharmaceuticals, Samsara Therapeutics and Cleara Biotech. As of February 2020, Apollo Ventures has made four investments. Their most recent investment was on October 3, 2019, when Aeovian Pharmaceuticals raised $37M.